A detoxified extract of rhus verniciflua stokes upregulated the expression of BDNF and GDNF in the rat brain and the human dopaminergic cell line SH-SY5Y

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 10, 2010, Pages 1997-2004

  Sapkota, Kumar ^a,d   Kim, Seung ^b   Kim, Myung Kon ^c   Kim, Sung Jun ^a  

^a Chosun University   (South Korea)

^b Kwangju University   (South Korea)

^c Chonbuk National University   (South Korea)

^d TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

Gene expression; Neuroprotection; Neurotrophic factors; Parkinson's disease; Rhus verniciflua

Indexed keywords

BRAIN-DERIVED NEUROTROPHIC FACTORS; CELL LINES; FOOD SUPPLEMENTS; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HERBAL MEDICINES; IN-VITRO; NEURODEGENERATIVE DISEASE; NEUROPROTECTION; NEUROTROPHIC FACTORS; PARKINSON'S DISEASE; PROTEIN LEVEL; RAT BRAIN; RHUS VERNICIFLUA;

ANIMALS; CELL CULTURE; DISEASES;

GENE EXPRESSION;

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; PLANT EXTRACT;

ANIMAL; ARTICLE; BRAIN; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; MALE; METABOLISM; POISON IVY; RAT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RHUS; RNA, MESSENGER; UP-REGULATION;

ANIMALIA; HEDERA; RATTUS; TOXICODENDRON VERNICIFLUUM;

EID: 78049363468     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100165     Document Type: Article

References (68)

1. Connor B and Dragunow M, Brain Res., 27, 1-39 (1998).
2. Siegel GJ and Chauhan NB, Brain Res. Brain Res. Rev., 33, 199-227 (2000).
3. Hefti F, Annu. Rev. Pharmacol. Toxicol., 37, 239-267 (1997).
4. Friedman WJ and Greene LA, Exp. Cell Res., 253, 131-142 (1999).
5. Yano H and Chao MV, Pharm. Acta Helv., 74, 253-260 (2000).
6. Saarma M and Sariola H, Microsc. Res. Tech., 45, 292-302 (1999).
7. Ebadi M, Bsher RM, Hidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, and Lassi NK, Neurochem. Int., 30, 347-374 (1997).
8. Jenner P and Olanow CW, Neurology, 47, 161-170 (1996).
9. Sun M, Kong L, Wang X, Lu XG, Gao Q, and Geller AI, Brain Res., 1052, 119-129 (2005).
10. Saavedra A, Baltazar G, and Duarte EP, Prog. Neurobiol., 86, 186-215 (2008).
11. Evans JR and Barker RA, Expert Opin. Ther. Targets, 12, 437-447 (2008).
12. Licker V, Kövari E, Hochstrasser DF, and Burkhard PR, J. Proteomics, 73, 10-29 (2009).
13. Manyam BV, Dhanasekaran M, and Hare TA, Phytother. Res., 18, 706-712 (2004).
14. Ramassamy C, Eur. J. Pharmacol., 545, 51-64 (2006).
15. Zhao B, Neurochem. Res., 34, 630-638 (2009).
16. Kim TJ, "Korea Resource Plants" Vol. II, Seoul National University Press, Seoul, pp. 292-297 (1996).
17. Lee JC, Kim J, Lim KT, Yang MS, and Jang YS, J. Biochem. Mol. Biol., 34, 250-258 (2001).
18. Lim KT, Hu C, and Kitts DD, Food Chem. Toxicol., 39, 229-237 (2001).
19. Kim IT, Park YM, Shin KM, Ha J, Choi J, Jung HJ, Park HJ, and Lee KT, J Ethnopharmacol., 94, 165-173 (2004).
20. Kitts DD and Lim KT, J. Toxicol. Environ. Health A, 64, 357-371 (2001).
21. Park KY, Jung GO, Lee KT, Choi JW, Choi MY, Kim GT, Jung JJ, and Park HJ, J. Ethnopharmacol., 90, 73-79 (2004).
22. Park BC, Lee YS, Park HJ, Kwak MK, Yoo BK, Kim JY, and Kim JA, Exp. Mol. Med., 39, 316-326 (2007).
23. Epstein WL, Cuits, 13, 544-548 (1974).
24. Choi HS, Kim MK, Park HS, Yun SE, Mun SP, Kim JS, Sapkota K, Kim S, Kim TY, and Kim SJ, Food Sci. Biotechnol., 16, 935-942 (2007).
25. Sapkota K, Kim S, Kim JS, Kim MK, Chun HS, and Kim SJ, J. Korean Soc. Appl. Biol. Chem., 52, 590-599 (2009).
26. Oh WS, Kim SJ, Kim MK, Yoo JC, Kim S, Han JM, and Choi HS, Korean patent, 10-0446137 (August 18, 2004).
27. Kim S, Kim SJ, Kim MK, Han JM, Choi HS, Kim JS, and Kim TY, Korean patent, 10-0553926 (February 14, 2006).
28. Kim S, Kim SJ, Kim MK, Han JM, Choi HS, Kim JS, and Kim TY, Korean patent, 10-0572405 (April 12, 2006).
29. Lee JC, Lim KT, and Jang YS, Biochim. Biophys. Acta, 1570, 181-191 (2002).
30. Jung CH, Jun CY, Lee S, Park CH, Cho K, and Ko SG, Biol. Pharm. Bull., 29, 1603-1607 (2006).
31. Jin CH, Shin EJ, Park JB, Jang CG, Li Z, Kim MS, Koo KH, Yoon HJ, Park SJ, Choi WC, Yamada K, Nabeshima T, and Kim HC, J. Neurosci. Res., 87, 3658-3670 (2009).
32. Maher P, Akaishi T, and Abe K, Proc. Natl. Acad. Sci. USA, 103, 16568-16573 (2006).
33. Mattson MP and Cheng A, Trends Neurosci., 29, 632-639 (2006).
34. Spencer JPE, Genes Nutr., 4, 243-250 (2009).
35. Wang R, Li YH, Xu Y, Li YB, Wu HL, Guo H, Zhang JZ, Zhang JJ, Pan XY, and Li XJ, Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 147-153 (2010).
36. Park JA, Kim S, Lee SY, Kim CS, Kim do K, Kim SJ, and Chun HS, Neuroreport, 19, 1301-1304 (2008).
37. Cho HS, Kim S, Lee SY, Park JA, Kim SJ, and Chun HS, Neurotoxicology, 29, 656-662 (2008).
38. Xu Y, Cui C, Pang C, Christen Y, and Luo Y, Eur. J. Neurosci., 26, 2931-2939 (2007).
39. Hashimoto M, Kanda M, Ikeno K, Hayashi Y, Nakamura T, Ogawa Y, Fukumitsu H, Nomoto H, and Furukawa S, Biosci. Biotechnol. Biochem., 69, 800-805 (2005).
40. Thoenen H, Trends Neurosci., 14, 165-170 (1991).
41. Chao MV, Rajagopal R, and Lee FS, Clin. Sci., 110, 167-173 (2006).
42. Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, Sakurai T, and Nishino H, Brain Res., 19, 76-84 (2001).
43. Cho T and Tiffany-Castiglioni E, J. Toxicol. Environ. Health A, 67, 987-1000 (2004).
44. Di Daniel E, Mudge AW, and Maycox PR, Bipolar Disord., 7, 33-41 (2005).
45. Encinas M, Iglesias M, Llecha N, and Comella JX, J. Neuro-chem., 73, 1409-1421 (1999).
46. Gomez-Santos C, Ferrer I, Reiriz J, Vinals F, Barrachina M, and Ambrosio S, Brain Res., 935, 32-39 (2002).
47. Hasegawa T, Matsuzaki M, Takeda A, Kikuchi A, Furukawa K, Shibahara S, and Itoyama Y, J. Neurochem., 87, 470-475 (2003).
48. Hong MS, Hong SJ, Barhoumi R, Burghardt RC, Donnelly KC, Wild JR, Venkatraj V, and Tiffany-Castiglioni E, Toxicol. Appl. Pharmacol., 186, 110-118 (2003).
49. Maruyama W, Nitta A, Shamoto-Nagai M, Hirata Y, Akao Y, Youdim MBH, Furukawa S, Nabeshima T, and Naoi M, Neurochem. Int., 44, 393-400 (2004).
50. Yang D, Peng C, Li X, Fan X, Li L, Ming M, Chen S, and Le W, J. Neurosci. Res., 86, 3393-3400 (2008).
51. Omata N, Murata T, Takamatsu S, Maruoka N, Mitsuya H, Yonekura Y, Fujibayashi Y, and Wada Y, Bipolar Disord., 10, 360-368 (2008).
52. Pliego Rivero FB, McCormack WJ, Jauniaux E, Stern GM, and Bradford HF, Brain Res. Dev. Brain Res., 114, 201-206 (1999).
53. Sagi Y, Mandel S, Amit T, and Youdim MB, Neurobiol. Dis., 25, 35-44 (2007).
54. Yasuhara T, Hara K, Maki M, Masuda T, Sanberg CD, Sanberg PR, Bickford PC, and Borlongan CV, Rejuvenation Res., 11, 201-214 (2008).
55. Li FQ, Cheng XX, Liang XB, Wang XH, Xue B, He QH, Wang XM, and Han JS, Exp. Neurol., 179, 28-37 (2003).
56. Marvanová M, Lakso M, Pirhonen J, Nawa H, Wong G, and Castrén E, Mol. Cell. Neurosci., 18, 247-258 (2001).
57. Hofer M, Pagliusi SR, Hohn A, Leibrock J, and Barde YA, EMBO J., 9, 2459-2464 (1990).
58. Yamamoto M, Sobue G, Yamamoto K, Terao S, and Mitsuma T, Neurochem. Res., 21, 929-938 (1996).
59. Kim JK, Jeon SM, Lee KM, Park ES, and Cho HJ, Neuro-science, 146, 1128-1136 (2007).
60. Yabe T, Wilson D, and Schwartz JP, J. Biol. Chem., 276, 43313-43319 (2001).
61. Blesch A and Tuszynski MH, J. Neurosci., 27, 10535-10545 (2007).
62. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, and Hong JS, Mol. Psychiatry, 11, 1116-1125 (2006).
63. Dawson NM, Hamid EH, Egan MF, and Meredith GE, Synapse, 39, 70-81 (2001).
64. Shieh PB and Ghosh A, J. Neurobiol., 41, 127-134 (1999).
65. Spencer JP, Proc. Nutr. Soc., 67, 238-252 (2008).
66. Leveugle B, Ding W, Laurence F, Dehouck MP, Scanameo A, Cecchelli R, and Fillit H, J. Neurochem., 70, 736-744 (1998).
67. Ma Q, Dudas B, Hejna M, Cornelli U, Lee JM, Lorens S, Mervis R, Hanin I, and Fareed J, Thromb. Res., 105, 447-453 (2002).
68. Sakurai-Yamashita Y, Kinugawa H, and Niwa M, Neurosci. Lett., 409, 30-34 (2006).